Drug Shortage Report for FOQUEST

Last updated on 2022-12-02 History
Report ID 151791
Drug Identification Number 02470357
Brand name FOQUEST
Common or Proper name methylphenidate hydrochloride Controlled Release Capsules
Company Name ELVIUM LIFE SCIENCES
Market Status MARKETED
Active Ingredient(s) METHYLPHENIDATE HYDROCHLORIDE
Strength(s) 100MG
Dosage form(s) CAPSULE (CONTROLLED RELEASE)
Route of administration ORAL ORAL
Packaging size 60
ATC code N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-01-07
Actual start date 2022-01-05
Estimated end date 2023-02-28
Actual end date
Shortage status Actual shortage
Updated date 2022-12-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3381 STEELES AVENUE EAST
TORONTO, ONTARIO
CANADA M2H 3S7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v59 2022-12-02 French Compare
v58 2022-12-02 English Compare
v57 2022-11-28 French Compare
v56 2022-11-28 English Compare
v55 2022-11-17 French Compare
v54 2022-11-17 English Compare
v53 2022-11-14 French Compare
v52 2022-11-14 English Compare
v51 2022-11-10 French Compare
v50 2022-11-10 English Compare
v49 2022-11-07 French Compare
v48 2022-11-07 English Compare
v47 2022-10-27 French Compare
v46 2022-10-27 English Compare
v45 2022-10-20 French Compare
v44 2022-10-20 English Compare
v43 2022-10-13 French Compare
v42 2022-10-13 English Compare
v41 2022-10-07 French Compare
v40 2022-10-07 English Compare

Showing 1 to 20 of 59